TotalMarketCap

BioNexus Gene Lab

BGLCNasdaq MalaysiaHealth CareMedical Specialities

Market cap

$2.512 M

$0.86 -10.78%

Close of 6 Nov 2026

As of 6 Nov 2026, BioNexus Gene Lab (BGLC) has a market capitalization of $2.51M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.42M

#3191 by revenue

Earnings

-$2.98M

Loss-making

Shares outstanding

2,933,442

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #40MDxHealthMDXH$14.8M
  2. #41American Shared Hospital ServicesAMS$7.88M
  3. #42AclarionACON$4.47M
  4. #43Advanced BiomedADVB$3.22M
  5. #44BioNexus Gene LabBGLC$2.51M

What if BioNexus Gene Lab were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,625,851

Per share 11,238,588× higher

Bitcoin $1.53T

$520,838.02

Per share 608,100× higher

Apple $5.02T

$1,709,863

Per share 1,996,337× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for BioNexus Gene Lab are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.